Liberty Biopharma (CVE:LTY) Shares Pass Below Fifty Day Moving Average – Time to Sell?

Liberty Biopharma Inc (CVE:LTY)’s share price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares.

Liberty Biopharma Stock Up ∞

The business has a 50 day moving average price of C$2.00 and a 200 day moving average price of C$2.00. The firm has a market capitalization of C$21.54 million and a P/E ratio of -12.66. The company has a debt-to-equity ratio of 8.19, a current ratio of 0.12 and a quick ratio of 0.12.

About Liberty Biopharma

Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.